Altamira Therapeutics Ltd (CYTO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2005 | 06-2005 | 03-2005 | 12-2004 | 09-2004 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -21,450 | -14,330 | -6,590 | -20,540 | -14,260 |
| Depreciation Amortization | 800 | 540 | 280 | 1,110 | 800 |
| Other Working Capital | -3,090 | -1,990 | -3,130 | 1,150 | 270 |
| Other Operating Activity | -120 | 500 | -30 | 610 | 130 |
| Operating Cash Flow | $-23,860 | $-15,280 | $-9,470 | $-17,670 | $-13,060 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -290 | -160 | -130 | -500 | -460 |
| Other Investing Activity | 22,720 | 22,720 | 13,020 | -6,330 | -10,520 |
| Investing Cash Flow | $22,430 | $22,560 | $12,890 | $-6,830 | $-10,980 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 11,850 | 200 | 180 | 23,920 | 23,870 |
| Financing Cash Flow | $11,850 | $200 | $180 | $23,920 | $23,870 |
| Beginning Cash Position | 13,040 | 13,040 | 13,040 | 13,630 | 13,630 |
| End Cash Position | 23,460 | 20,530 | 16,650 | 13,040 | 13,460 |
| Net Cash Flow | $10,420 | $7,480 | $3,600 | $-580 | $-170 |
| Free Cash Flow | |||||
| Operating Cash Flow | -23,860 | -15,280 | -9,470 | -17,670 | -13,060 |
| Free Cash Flow | -23,860 | -15,280 | -9,470 | -17,670 | -13,060 |